Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity

JAMA Oncol. 2021 Oct 1;7(10):1578-1579. doi: 10.1001/jamaoncol.2021.3341.

Thomas M Schindler^{1

2}, Jacqueline M Marchington^{3

4}, Gail V Flores^{5

6}

¹ European Medical Writers Association Special Interest Group Medical Communications.
² Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany.
³ Ethics and Standards Committee, International Society for Medical Publication Professionals, Tarrytown, New York.
⁴ Caudex, McCann Health Medical Communications Ltd, Oxford, United Kingdom.
⁵ President, American Medical Writers Association, Rockville, Maryland.
⁶ Encore Biomedical Communications LLC, Encinitas, California.

No abstract available

Publication types